Mon 23 November 2020:
G20 leaders meeting remotely pledged on Sunday to “spare no effort” to ensure the fair distribution of coronavirus vaccines worldwide, but offered no specific new funding to meet that goal.
KAZAKHSTAN FORMS NEW CABINET
AFTER PARLIAMENTARY POLLS
VIOLENCE FLARES FOR THIRD
DAY IN SUDAN’S DARFUR
PALESTINIANS EXPECTED TO RECEIVE
FIRST BATCH OF RUSSIAN VACCINES
NO INDICATION OF INSIDER THREAT
BEFORE JOE BIDEN INAUGURATION:
ACTING PENTAGON CHIEF
SOUTH AFRICA COVID-19 CASES DROP,
AS SCIENTISTS STUDY NEW VARIANT
NEW WAY TO RECYCLE SOFT PLASTICS
YOU CAN ENHANCE CONCRETE WITH IT
ISIS LANDMINES KILL 10 RUSSIA-
BACKED FIGHTERS IN SYRIA’S HOMS
BABRI SETTLEMENT MOSQUE
PROJECT TO START JAN 26
DESPITE OBJECTION FROM
DESPITE PANDEMIC, CHINA’S
ECONOMY GREW 2.3% IN 2020
WANTS 70% VACCINATION
RATE IN BLOC BY SUMMER
Regarding coronavirus vaccines, tests and treatments, the leaders said: “We will spare no effort to ensure their affordable and equitable access for all people.”
The summit also discussed how to help stave off possible credit defaults among developing nations as their debt soars in the economic upheaval the virus has unleashed. The G20 had already extended a debt service suspension initiative (DSSI) for developing countries until June next year, but Guterres had pushed for a commitment to extend it until the end of 2021.
The president of the World Bank, David Malpass, had told the G20 creditors at the meeting: “We have to avoid doing too little now and then suffering disorderly defaults and repeated debt restructurings like in the 1980s.”
The UN secretary general, António Guterres, said: “The recent breakthroughs on Covid-19 vaccines offer a ray of hope. But that ray of hope needs to reach everyone. That means ensuring that vaccines are treated as a global public good, a people’s vaccine accessible and affordable to everyone, everywhere,” he said.
“This is not a ‘do-good’ exercise. It is the only way to stop the pandemic dead in its tracks. Solidarity is indeed survival.”
The final G20 communique simply said: “We have mobilised resources to address the immediate financing needs in global health to support the research, development, manufacturing and distribution of safe and effective Covid-19 diagnostics, therapeutics and vaccines.
FOLLOW INDEPENDENT PRESS:
TWITTER (CLICK HERE)
FACEBOOK (CLICK HERE)
Think your friends would be interested? Share this story!